Q1 2026 Revolution Medicines Inc Earnings Call Transcript
Good day and thank you for standing by. Welcome to the Revolution Medicines Q1 2026 earnings call.
(Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand it over to Ryan Asay, Senior VP of Corporate Affairs. Ryan, you have the floor.
Thank you, operator. Welcome, everyone, to the first-quarter 2026 earnings call.
Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and Chief Executive Officer; Dr. Alan Sandler, our Chief Development Officer; and Jack Anders, the Chief Financial Officer.
Dr. Steve Kelsey, our President of R&D; Dr. Wei Lin, our Chief Medical Officer; and Anthony Mancini, our Chief Global Commercialization Officer, will join us for the Q&A portion of today's call.
We would like to inform you that certain statements we make during this call will be forward-looking. Because such statements deal with future events and are subject to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
